RE:RE:Where does the money come from?Absolutely true, Sleepydog!
Mindbend has been at this for a little over 4 years which would explain the "current" difference in market cap. Being an American entity where 95% of their investors trade through one of the NASDAQ exchanges doesn't hurt either (10x the potential investors). As a consequence they just delisted from a Canadian exchange to cut costs etc and because of the practicality of doing so.
Having said that, I've read the research from MindMed and they are, as you say, essentially at the same point with their trials. In less time, with a titratable form of LSD, take home experimental design and some significant results, the only thing missing thus far for MBIO is exposure. When that changes ...and it should, investors will be well rewarded I expect.
If nothing else, MindMed provides a great deal of legitimacy to the research and potential benefits to mental health sufferers and shareholders of MBIO.